Jacob Alejandro Strouse

Dr. Jacob Alejandro Strouse


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IKIvelina Kioutchoukova
Ivelina Kioutchoukova
DFDevon Foster
Devon Foster
RTRajvi Thakkar
Rajvi Thakkar
CCChristopher Ciesla
Christopher Ciesla
JCJake Salvatore Cabassa
Jake Salvatore Cabassa
Brandon Lucke-WoldBrandon Lucke-Wold
Brandon Lucke-Wold
Neurocutaneous disorders, also known as phakomatoses, are congenital and acquired syndromes resulting in simultaneous neurologic and cutaneous involvement. In several of these conditions, the genetic phenomenon is understood, providing a pivotal role in the development of therapeutic options. This review encompasses the discussion of the genetic and clinical involvement of neurocutaneous disorders, and examines clinical management and treatment options. With the current advances in genetics, the role of precision medicine and targeted therapy play a substantial role in addressing the management of these conditions. The interconnectedness between therapeutic options highlights the importance of precision medicine in treating each disorder’s unique molecular pathway. This review provides an extensive synthesis of ongoing and current therapeutics in the management of such clinically unique and challenging conditions.

17 January 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
IKIvelina Kioutchoukova
Ivelina Kioutchoukova
DFDevon Foster
Devon Foster
RTRajvi Thakkar
Rajvi Thakkar
CCChristopher Ciesla
Christopher Ciesla
JCJake Salvatore Cabassa
Jake Salvatore Cabassa
Brandon Lucke-WoldBrandon Lucke-Wold
Brandon Lucke-Wold
Neurocutaneous disorders, also known as phakomatoses, are congenital and acquired syndromes resulting in simultaneous neurologic and cutaneous involvement. In several of these conditions, the genetic phenomenon is understood, providing a pivotal role in the development of therapeutic options. This review encompasses the discussion of the genetic and clinical involvement of neurocutaneous disorders and examines clinical management and treatment options. With the current advances in genetics, the role of precision medicine and targeted therapy plays a substantial role in addressing management of these conditions. The interconnectedness between therapeutic options highlights the importance of precision medicine in treating each disorder’s unique molecular pathway. This review provides an extensive synthesis of ongoing and current therapeutics in the management of such clinically unique and challenging conditions.